Navigation Links
Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2011 Financial Results and Reviews Recent Developments
Date:3/14/2012

(1,806)28(1,766)1,016  Total interest and other expense, net

(5,353)(5,810)(26,425)(28,179)Net loss

(23,682)(28,241)(109,224)(124,534)Deemed dividend related to beneficial conversion feature of convertible preferred stock

00(2,260)0Net loss allocable to common stockholders

$(23,682)$(28,241)$(111,484)$(124,534)Net loss per share allocable to common stockholders:Basic

$(0.16)$(0.23)$(0.80)$(1.14)Diluted

$(0.16)$(0.23)$(0.80)$(1.14)Shares used in calculating net loss per share allocable to common stockholders:Basic

146,028121,415139,171109,573Diluted

146,028121,415139,171109,573Note: The Condensed Consolidated Statements of Operations has been derived from the audited financial statements for the year ended December 31, 2010 and from the unaudited financial statements for the year ended December 31, 2011.Arena Pharmaceuticals, Inc.Condensed Consolidated Balance Sheet Data(In thousands)December 31, 2011December 31, 2010**Assets  Cash, cash equivalents & short-term investments

$ 57,632$ 150,669  Accounts receivable

6073,499  Other current assets

2,0212,638  Land, property & equipment, net

82,06691,533  Acquired technology & other non-current assets

14,80318,023Total assets

$ 157,129$ 266,362Liabilities and Stockholders' Equity  Accounts payable and accrued liabilities

$
9,574$   10,680  Total deferred revenues

44,68248,077  Total derivative liabilities

1,6172,271  Total note payable to Siegfried

010,361  Total note payable to Deerfield **

14,69837,777  Total lease financing obligations & other long-term liabilities

75,99677,181  Total stockholders' equity

10,56280,015Total liabilities & stockholders' equity

$ 157,129$ 266,362* The Condensed Consolidated Balance Sheet Data has been derived from the audited financial sta
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Wednesday, March 14
2. Arena Pharmaceuticals Files European Marketing Authorization Application for Lorcaserin for Weight Control
3. Arena Pharmaceuticals to Present at the Citi 2012 Global Health Care Conference
4. Arena Pharmaceuticals Receives Notice from FDA of Advisory Committee Meeting for Lorcaserin
5. Arena Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
6. Arena Submits Response to FDA Complete Response Letter for Lorcaserin
7. Arena Pharmaceuticals to Present at the Oppenheimer 22nd Annual Healthcare Conference
8. Arena Pharmaceuticals to Present at the Piper Jaffray 23rd Annual Health Care Conference
9. Arena Pharmaceuticals Announces Third Quarter 2011 Financial Results
10. Arena Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
11. Robert Hoffman to Rejoin Arena Pharmaceuticals as Vice President, Finance and Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... , July 29, 2014 ... Market Research "Orthopedic Trauma Fixation Devices Market - Global ... - 2020", the global orthopedic trauma fixation devices market ... is expected to grow at a CAGR of 7.2% ... of USD 9.3 billion in 2020. Browse ...
(Date:7/29/2014)... LAKE CITY and ... -- EastGate Acquisitions Corporation (OTCBB: ESAQ), an ... in the development of improved novel formulations ... active molecules announces expansion of its pharmaceutical ... new development direction includes large molecule drugs that ...
(Date:7/29/2014)... Calif. , July 29, 2014  Based ... response systems (PERS) market, Frost & Sullivan recognizes ... Sullivan Award for Price Performance Value Leadership. MobileHelp,s ... directly captures expectations for tech progression in personal ... consumers for these solutions. MobileHelp is ...
Breaking Medicine Technology:Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 2Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 3Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 4EastGate Acquisitions Announces Expansion of its Pharmaceutical Developments Implementing its Sub-Micron Platform Technology 2EastGate Acquisitions Announces Expansion of its Pharmaceutical Developments Implementing its Sub-Micron Platform Technology 3EastGate Acquisitions Announces Expansion of its Pharmaceutical Developments Implementing its Sub-Micron Platform Technology 4Frost & Sullivan Applauds MobileHelp for its Targeted Supplies for the PERS Market 2Frost & Sullivan Applauds MobileHelp for its Targeted Supplies for the PERS Market 3
... IRVINE, Calif., and BURLINGTON, Mass., July 18, 2011 ... marketer of minimally invasive treatments for aortic disorders, and ... of peripheral vascular devices and implants, announced today that ... for LeMaitre,s distribution rights of Endologix,s aortic endovascular products ...
... Pa., July 18, 2011 Wolters Kluwer Pharma Solutions, ... pharmaceutical and healthcare professionals, today announced strong impact ... drug therapy and patient management journals.  11 of ... their performance in 2010 a ccording to the annual ...
Cached Medicine Technology:Endologix and LeMaitre Vascular Enter Early Termination Agreement for European Distribution Rights of Endologix Products 2Endologix and LeMaitre Vascular Enter Early Termination Agreement for European Distribution Rights of Endologix Products 3Endologix and LeMaitre Vascular Enter Early Termination Agreement for European Distribution Rights of Endologix Products 4Adis Journals Make Impressive Impact Factor Gains 2Adis Journals Make Impressive Impact Factor Gains 3
(Date:7/29/2014)... News) -- Although the bite of a brown recluse ... left alone, an expert notes. It,s still important ... to a brown recluse spider bite, warned Dr. Donna ... since these potentially dangerous bites are on the rise. ... do nothing. The [bite] has classic characteristics, but if ...
(Date:7/29/2014)... County, NJ (PRWEB) July 29, 2014 ... two leading pediatricians have joined our network, CarePoint ... Politis and Dr. Sushma Kaki. Hundreds of highly ... Group, a comprehensive network of top doctors and ... of specialties. This latest acquisition represents CarePoint Health’s ...
(Date:7/29/2014)... Alan Mozes HealthDay Reporter ... adult autism patients with just a single dose of the ... and emotions, Japanese researchers report. Known as the "love ... emotional bonding between lovers, and between mothers and their children. ... a key area of the brain that has long been ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 Summer is here, and ... means enjoying a hike, swimming in a pool or laying out ... for fleas and ticks. The Puppy Store is here to help ... summer months. , It’s almost impossible to completely keep fleas and ... to minimize the chances of their pets coming into contact with ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 Bret ... LLP ’s Boise office, has been appointed to the ... Greater Idaho. , Busacker is an experienced business attorney ... matters. He advises clients on a wide spectrum of ... plan administration, compliance, and governance concerns. His clients include ...
Breaking Medicine News(10 mins):Health News:Brown Recluse Spider Bites on the Rise, Expert Warns 2Health News:Dr. Politis and Dr. Kaki Join CarePoint Health Medical Group 2Health News:Dr. Politis and Dr. Kaki Join CarePoint Health Medical Group 3Health News:'Love Hormone' Oxytocin May Help Some With Autism 2Health News:'Love Hormone' Oxytocin May Help Some With Autism 3Health News:Protect Dogs From Fleas and Ticks During the Summer 2Health News:Holland & Hart Partner Brett Busacker Appointed to Board of Directors for American Red Cross of Greater Idaho 2
... PALATINE, Ill., July 17 Addus HomeCare Corporation announced ... with the U.S. Securities and Exchange Commission (SEC) relating to a ... of shares to be offered and the price range for the ... in the proposed offering will be offered by Addus HomeCare Corporation. ...
... WASHINGTON, July 17 The Pharmacy Technician ... 25,000 pharmacists and technicians have accessed two web-based and ... the American Society of Health-System Pharmacists (ASHP) and funded ... in Sterile IV Compounding: Challenges, Opportunities, and Competencies" and ...
... daily tablet, study finds , FRIDAY, July 17 (HealthDay News) ... the progression of chronic kidney disease, a new study has ... patients with metabolic acidosis, a condition caused by low bicarbonate ... of which took a small daily tablet of sodium bicarbonate ...
... , Patient Advocates , ... Home Oxygen Therapy Act, Oppose Additional Cuts to Oxygen Benefit ... Asking members of Congress to support patient-focused reform of the ... National Emphysema/COPD Association (NECA), a national advocacy organization representing patients with ...
... , , HARRISBURG, ... of the state,s four Blue Cross and Blue Shield insurance companies, ... Blue Cross, to determine if any of them were engaged in ... Commissioner Joel Ario announced today. , , ...
... may determine child,s temperament, study finds , FRIDAY, July 17 ... a fussy one may have nothing to do with your ... a particular pattern of brain activity may determine a child,s ... the interaction between the DRD4 gene and activity in the ...
Cached Medicine News:Health News:Addus HomeCare Corporation Files Registration Statement 2Health News:Over 25,000 Pharmacists and Technicians Access PTCB Funded Web-Based Continuing Education Programs 2Health News:Over 25,000 Pharmacists and Technicians Access PTCB Funded Web-Based Continuing Education Programs 3Health News:Baking Soda May Be Key Ingredient for Kidney Patients 2Health News:Home Oxygen Patients and Family Members Visit Capitol Hill to Ask Congress to Protect Medicare Home Oxygen Therapy Benefit 2Health News:Pennsylvania Insurance Department Examinations to Focus on Health Insurance Competition 2Health News:Pennsylvania Insurance Department Examinations to Focus on Health Insurance Competition 3Health News:Easy Baby or Fussy -- It May Be Out of Mom's Control 2
... range of procedure-specific designs for all surgical ... the world. Surgical needs such as strength, ... using different materials to provide performance where ... in a wide array of formats, including ...
NEAR-SkinTM Incise Drape Aggressive adhesive with no residue High moisture permeability for extended adhesion Low-glare matte finish film Product number identification...
The Model 273 is a general purpose instrument with output that may be either DC-coupled for very slow changes such as venous occlusion and penile tumescence studies or AC-coupled for respiratory or p...
... NEVA™ System is designed to ... within the penis nocturnally. Three ... monitor and record impedance data ... in penile blood volume. The ...
Medicine Products: